121 related articles for article (PubMed ID: 10082505)
1. Erythropoietin depresses nitric oxide synthase expression by human endothelial cells.
Wang XQ; Vaziri ND
Hypertension; 1999 Mar; 33(3):894-9. PubMed ID: 10082505
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade.
Ni Z; Wang XQ; Vaziri ND
Hypertension; 1998 Oct; 32(4):724-9. PubMed ID: 9774370
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells.
Ding Y; Vaziri ND
Hypertension; 1998 Oct; 32(4):718-23. PubMed ID: 9774369
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells.
Beleslin-Cokic BB; Cokic VP; Yu X; Weksler BB; Schechter AN; Noguchi CT
Blood; 2004 Oct; 104(7):2073-80. PubMed ID: 15205261
[TBL] [Abstract][Full Text] [Related]
5. Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric-oxide synthase expression.
Ding Y; Vaziri ND
J Pharmacol Exp Ther; 2000 Feb; 292(2):606-9. PubMed ID: 10640297
[TBL] [Abstract][Full Text] [Related]
6. cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide.
Vaziri ND; Wang XQ
Hypertension; 1999 Dec; 34(6):1237-41. PubMed ID: 10601124
[TBL] [Abstract][Full Text] [Related]
7. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin.
d'Uscio LV; Smith LA; Santhanam AV; Richardson D; Nath KA; Katusic ZS
Hypertension; 2007 May; 49(5):1142-8. PubMed ID: 17372034
[TBL] [Abstract][Full Text] [Related]
8. Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells.
Vogel V; Kramer HJ; Bäcker A; Meyer-Lehnert H; Jelkmann W; Fandrey J
Am J Hypertens; 1997 Mar; 10(3):289-96. PubMed ID: 9056686
[TBL] [Abstract][Full Text] [Related]
9. Role of transient receptor potential vanilloid 1 in regulating erythropoietin-induced activation of endothelial nitric oxide synthase.
Yu YB; Su KH; Kou YR; Guo BC; Lee KI; Wei J; Lee TS
Acta Physiol (Oxf); 2017 Feb; 219(2):465-477. PubMed ID: 27232578
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q
Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin down-regulates, whereas arginine analogs up-regulates, endothelial nitric-oxide synthase expression in coronary endothelial cells.
Vaziri ND; Ding Y; Ni Z; Barton CH
J Pharmacol Exp Ther; 2005 Apr; 313(1):121-6. PubMed ID: 15640399
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and hypoxia increase erythropoietin receptor and nitric oxide levels in lung microvascular endothelial cells.
Beleslin-Čokić BB; Cokić VP; Wang L; Piknova B; Teng R; Schechter AN; Noguchi CT
Cytokine; 2011 May; 54(2):129-35. PubMed ID: 21324713
[TBL] [Abstract][Full Text] [Related]
13. Short-term exposure of erythropoietin impairs endothelial function through inhibition of nitric oxide production and eNOS mRNA expression in the rat pulmonary artery.
Sultan F; Singh TU; Kumar T; Rungsung S; Rabha DJ; Vishwakarma A; Sukumaran SV; Kandasamy A; Parida S
Pharmacol Rep; 2017 Aug; 69(4):658-665. PubMed ID: 28527876
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits.
Noguchi K; Yamashiro S; Matsuzaki T; Sakanashi M; Nakasone J; Miyagi K; Sakanashi M
Br J Pharmacol; 2001 Jun; 133(3):395-405. PubMed ID: 11375256
[TBL] [Abstract][Full Text] [Related]
16. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.
Gonzalez C; Corbacho AM; Eiserich JP; Garcia C; Lopez-Barrera F; Morales-Tlalpan V; Barajas-Espinosa A; Diaz-Muñoz M; Rubio R; Lin SH; Martinez de la Escalera G; Clapp C
Endocrinology; 2004 Dec; 145(12):5714-22. PubMed ID: 15358675
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells.
Zhao X; Li X; Trusa S; Olson SC
Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794
[TBL] [Abstract][Full Text] [Related]
18. AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase.
Su KH; Yu YB; Hou HH; Zhao JF; Kou YR; Cheng LC; Shyue SK; Lee TS
J Cell Physiol; 2012 Aug; 227(8):3053-62. PubMed ID: 22021095
[TBL] [Abstract][Full Text] [Related]
19. Neuronal nitric oxide synthase is required for erythropoietin stimulated erythropoiesis in mice.
Lee J; Dey S; Rajvanshi PK; Merling RK; Teng R; Rogers HM; Noguchi CT
Front Cell Dev Biol; 2023; 11():1144110. PubMed ID: 36895793
[No Abstract] [Full Text] [Related]
20. Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells.
Li H; Burkhardt C; Heinrich UR; Brausch I; Xia N; Förstermann U
Circulation; 2003 May; 107(18):2348-54. PubMed ID: 12707234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
